Symbol | Exchange | Currency |
|---|
Investing.com – U.S. stocks were mixed after the close on Thursday, as gains in the Consumer Services, Healthcare and Telecoms sectors led shares higher while losses in the...
Pre-Open Stock Movers: Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) 43% HIGHER; announced the successful completion of its pre-IND (Investigational New Drug) meeting process with...
Investing.com – U.S. stocks were lower after the close on Friday, as losses in the Basic Materials, Industrials and Healthcare sectors led shares lower. At the close in NYSE, the...
Flex Pharma Inc. (NASDAQ:FLKS) announced that the company is ending the phase II studies for its pipeline candidate FLX-787 in two indications. The company discontinued the...
Salarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical need. In addition, the Company is also developing treatments for cancers caused by dysregulated gene expression. The Company is developing two classes of drugs that address gene dysregulation: epigenetic drugs and targeted protein degraders. The Company’s technologies have the potential to work in both liquid and solid tumors. The Company’s pipeline consists of two compounds: seclidemstat (SP-2577), which is a small molecule that inhibits the epigenetic enzyme lysine specific demethylase 1 (LSD1); SP-2577 uses a reversible mechanism to inhibit LSD1’s enzymatic and scaffolding properties and thereby treat and prevent cancer progression, and SP-3164, which is a cereblon binding molecular glue and has a development path in hematological cancer and potential in solid tumors.
| Average | 70.5000 (+2,653.9063% Upside) |
| High | 125.0000 |
| Low | 16.0000 |
| Price | 2.5600 |
| No. of Analysts | 2 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Sell | Sell | Strong Sell |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Buy | Strong Sell |
| Summary | Strong Sell | Strong Sell | Strong Sell | Neutral | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 1.73 | 1.8222 | 1.61 | -0.0800 | -4.42% | 90.11K | NASDAQ | |||
| 27.44 | 27.84 | 27.16 | -0.15 | -0.54% | 684.60K | NYSE | |||
| 3.12 | 3.32 | 3.06 | -0.08 | -2.50% | 1.86M | NASDAQ | |||
| 108.49 | 111.99 | 80.74 | +27.49 | +33.94% | 373.96K | NASDAQ | |||
| 14.90 | 15.09 | 13.96 | +3.69 | +32.92% | 19.46M | NASDAQ | |||
| 1.32 | 1.44 | 1.25 | -0.080 | -5.71% | 234.42K | NASDAQ | |||
| 0.31 | 0.31 | 0.26 | +0.05 | +17.30% | 1.64M | NASDAQ | |||
| 79.61 | 79.82 | 77.67 | +2.13 | +2.75% | 554.96K | NYSE | |||
| 3.06 | 3.67 | 2.62 | +0.44 | +16.79% | 5.47M | NASDAQ | |||
| 0.77 | 0.799 | 0.592 | +0.140 | +22.22% | 2.34M | NASDAQ | |||
| 149.30 | 149.63 | 148.15 | +1.52 | +1.03% | 802.49K | NYSE | |||
| 0.489 | 0.49 | 0.42 | +0.074 | +17.71% | 977.85K | NASDAQ | |||
| 1.20 | 1.24 | 1.17 | 0.00 | 0.00% | 3.30M | NASDAQ | |||
| 55.34 | 55.38 | 53.14 | +2.13 | +4.00% | 953.60K | NYSE | |||
| 117.50 | 117.59 | 115.00 | +1.76 | +1.52% | 391.89K | NYSE |